Regeneron Pharmaceuticals, Inc. acquired a significant new investment from Fox Run Management L.L.C., adding 1,734 shares worth about $1.1 million. The biopharmaceutical giant reported an impressive ...

Celldex will stop development of barzolvolimab in eosinophilic esophagitis, but it will continue progressing the drug in ...

Shares of Regeneron Pharmaceuticals Inc. rallied 3.36% to $591.01 Wednesday, on what proved to be an all-around mixed trading ...

The hits just keep on coming for Regeneron’s Eylea franchise. | The FDA has extended its target action dates for two ...

Regeneron Pharmaceuticals ( NASDAQ: REGN) announced that the U.S. FDA has extended the target action dates for two regulatory ...

The CDMO will be cutting 350 jobs at its Baltimore gene therapy site after a major client’s demand shift, less than a year after Novo Holdings’ $16.5 billion acquisition.

Regeneron Pharmaceuticals, Inc. (REGN) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has extended ...

In a study known as CROWNS-2 published in JAMA, the researchers randomly assigned 180 adults with CRSwNP to stapokibart (300 ...

Regeneron Pharmaceuticals, Inc. saw a notable boost in its financial performance this quarter. The Public Sector Pension ...

After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...

Michael Burry's Scion Asset Management switched out a bet against Nvidia for a wager on Meta as it overhauled its stock ...

Burry, known as the "Big Short" investor for his prescient calls ahead of the 2008 U.S. housing market crash, placed bets ...